Highlighting Immunotherapy Progress in Bladder Cancer
Shilpa Gupta, MD, discusses the progress over the last few years in bladder cancer.
Shilpa Gupta, MD, genitourinary oncologist at the University of Minnesota, discusses the progress made with immunotherapy in bladder cancer over the last few years.
There has been many advances in terms of immunotherapy in this patient population, and many trials are combining chemotherapy with these agents in the hopes of improving overall survival and gaining more durable responses, says Gupta. Later this year, we will learn more about these data as they read out.
Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond
March 21st 2025Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.
Read More
